Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2015, Article ID 624132, 11 pages
http://dx.doi.org/10.1155/2015/624132
Research Article

A Novel Korean Red Ginseng Compound Gintonin Inhibited Inflammation by MAPK and NF-κB Pathways and Recovered the Levels of mir-34a and mir-93 in RAW 264.7 Cells

1Laboratory of Veterinary Physiology & Cell Signaling, College of Veterinary Medicine, Kyungpook National University, Daegu 41566, Republic of Korea
2Laboratory of Medical Imaging, College of Veterinary Medicine, Kyungpook National University, Daegu 41566, Republic of Korea
3Department of Parasitology and Tropical Medicine, Kyungpook National University School of Medicine, Daegu 41944, Republic of Korea
4Laboratory of Parasitology, College of Veterinary Medicine, Kyungpook National University, Daegu 41566, Republic of Korea
5Institute of Agriculture and Life Science, Gyeongsang National University, Jinju 52828, Republic of Korea
6College of Korean Medicine, Daegu Haany University, Daegu 42158, Republic of Korea
7Research Center, Dongnam Institute of Radiological and Medical Sciences, Busan 46033, Republic of Korea
8Department of Physiology, College of Veterinary Medicine and BioMolecular Informatics Center, Konkuk University, Seoul 05029, Republic of Korea

Received 5 June 2015; Accepted 6 August 2015

Academic Editor: Raffaele Capasso

Copyright © 2015 Evelyn Saba et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Banerjee and S. Gerondakis, “Coordinating TLR-activated signaling pathways in cells of the immune system,” Immunology and Cell Biology, vol. 85, no. 6, pp. 420–424, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Akira and K. Takeda, “Toll-like receptor signalling,” Nature Reviews Immunology, vol. 4, no. 7, pp. 499–511, 2004. View at Publisher · View at Google Scholar
  3. G. M. Barton and R. Medzhitov, “Toll-like receptor signaling pathways,” Science, vol. 300, no. 5625, pp. 1524–1525, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. K. Honda and T. Taniguchi, “IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors,” Nature Reviews Immunology, vol. 6, no. 9, pp. 644–658, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Hawiger, “Innate immunity and inflammation: a transcriptional paradigm,” Immunologic Research, vol. 23, no. 2-3, pp. 99–109, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. J. K. Bell, G. E. D. Mullen, C. A. Leifer, A. Mazzoni, D. R. Davies, and D. M. Segal, “Leucine-rich repeats and pathogen recognition in Toll-like receptors,” Trends in Immunology, vol. 24, no. 10, pp. 528–533, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. Y.-J. Kim, J.-N. Jeon, M.-G. Jang et al., “Ginsenoside profiles and related gene expression during foliation in panax ginseng Meyer,” Journal of Ginseng Research, vol. 38, no. 1, pp. 66–72, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. S. M. Jeong, J.-H. Lee, S. Kim et al., “Ginseng saponins induce store-operated calcium entry in Xenopus oocytes,” British Journal of Pharmacology, vol. 142, no. 3, pp. 585–593, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. S. H. Hwang, B.-H. Lee, H.-J. Kim et al., “Suppression of metastasis of intravenously-inoculated B16/F10 melanoma cells by the novel ginseng-derived ingredient, gintonin: involvement of autotaxin inhibition,” International Journal of Oncology, vol. 42, no. 1, pp. 317–326, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. S.-Y. Nah, D.-H. Kim, and H. Rhim, “Ginsenosides: are any of them candidates for drugs acting on the central nervous system?” CNS Drug Reviews, vol. 13, no. 4, pp. 381–404, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. M. K. Pyo, S.-H. Choi, T.-J. Shin et al., “A simple method for the preparation of crude gintonin from ginseng root, stem, and leaf,” Journal of Ginseng Research, vol. 35, no. 2, pp. 209–218, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. N. Bushati and S. M. Cohen, “microRNA functions,” Annual Review of Cell and Developmental Biology, vol. 23, no. 1, pp. 175–205, 2007. View at Publisher · View at Google Scholar
  13. V. Ambros, “microRNAs: tiny regulators with great potential,” Cell, vol. 107, no. 7, pp. 823–826, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. D. P. Bartel, “MicroRNAs: genomics, biogenesis, mechanism, and function,” Cell, vol. 116, no. 2, pp. 281–297, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. S.-H. Choi, T.-J. Shin, B.-H. Lee et al., “An edible gintonin preparation from ginseng,” Journal of Ginseng Research, vol. 35, no. 4, pp. 471–478, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. S. H. Hwang, T.-J. Shin, S.-H. Choi et al., “Gintonin, newly identified compounds from ginseng, is novel lysophosphatidic acids-protein complexes and activates G protein-coupled lysophosphatidic acid receptors with high affinity,” Molecules and Cells, vol. 33, no. 2, pp. 151–162, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. P. Jiang, R. Liu, Y. Zheng et al., “MiR-34a inhibits lipopolysaccharide-induced inflammatory response through targeting Notch1 in murine macrophages,” Experimental Cell Research, vol. 318, no. 10, pp. 1175–1184, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Xu, H. Jin, X. Yang et al., “MicroRNA-93 inhibits inflammatory cytokine production in LPS-stimulated murine macrophages by targeting IRAK4,” FEBS Letters, vol. 588, no. 9, pp. 1692–1698, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Y. Nah, “Gintonin: a novel ginseng-derived ligand that targets G protein-coupled lysophosphatidic acid receptors,” Current Drug Targets, vol. 13, no. 13, pp. 1659–1664, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Miwa, D. J. Stuehr, M. A. Marletta, J. S. Wishnok, and S. R. Tannenbaum, “Nitrosation of amines by stimulated macrophages,” Carcinogenesis, vol. 8, no. 7, pp. 955–958, 1987. View at Publisher · View at Google Scholar · View at Scopus
  21. C. A. Dinarello, “Proinflammatory cytokines,” Chest, vol. 118, no. 2, pp. 503–508, 2000. View at Publisher · View at Google Scholar · View at Scopus
  22. P. N. Moynagh, “The NF-kappaB pathway,” Journal of Cell Science, vol. 118, no. 20, pp. 4589–4592, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. N. D. Perkins, “Integrating cell-signalling pathways with NF-κB and IKK function,” Nature Reviews Molecular Cell Biology, vol. 8, no. 1, pp. 49–62, 2007. View at Publisher · View at Google Scholar
  24. A. Plotnikov, E. Zehorai, S. Procaccia, and R. Seger, “The MAPK cascades: signaling components, nuclear roles and mechanisms of nuclear translocation,” Biochimica et Biophysica Acta—Molecular Cell Research, vol. 1813, no. 9, pp. 1619–1633, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. J. Hambleton, S. L. Weinstein, L. Lem, and A. L. Defranco, “Activation of c-Jun N-terminal kinase in bacterial lipopolysaccharide-stimulated macrophages,” Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 7, pp. 2774–2778, 1996. View at Publisher · View at Google Scholar · View at Scopus
  26. T. Zarubin and J. Han, “Activation and signaling of the p38 MAP kinase pathway,” Cell Research, vol. 15, no. 1, pp. 11–18, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. E. van Rooij, A. L. Purcell, and A. A. Levin, “Developing microRNA therapeutics,” Circulation Research, vol. 110, no. 3, pp. 496–507, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. M. A. Nahid, M. Satoh, and E. K. L. Chan, “MicroRNA in TLR signaling and endotoxin tolerance,” Cellular and Molecular Immunology, vol. 8, no. 5, pp. 388–403, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. L. Lai, Y. Song, Y. Liu et al., “MicroRNA-92a negatively regulates toll-like receptor (TLR)-triggered inflammatory response in macrophages by targeting MKK4 kinase,” Journal of Biological Chemistry, vol. 288, no. 11, pp. 7956–7967, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Lorente-Cebrián, N. Mejhert, A. Kulyté et al., “microRNAs regulate human adipocyte lipolysis: effects of miR-145 are linked to TNF-α,” PLoS ONE, vol. 9, no. 1, Article ID e86800, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. J. Qi, Y. Qiao, P. Wang, S. Li, W. Zhao, and C. Gao, “MicroRNA-210 negatively regulates LPS-induced production of proinflammatory cytokines by targeting NF-κB1 in murine macrophages,” FEBS Letters, vol. 586, no. 8, pp. 1201–1207, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. I. Shaked, A. Meerson, Y. Wolf et al., “MicroRNA-132 potentiates cholinergic anti-inflammatory signaling by targeting acetylcholinesterase,” Immunity, vol. 31, no. 6, pp. 965–973, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. G.-P. Tian, W.-J. Chen, P.-P. He et al., “MicroRNA-467b targets LPL gene in RAW 264.7 macrophages and attenuates lipid accumulation and proinflammatory cytokine secretion,” Biochimie, vol. 94, no. 12, pp. 2749–2755, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. Y. Wei, M. Nazari-Jahantigh, P. Neth, C. Weber, and A. Schober, “MicroRNA-126, -145, and -155: a therapeutic triad in atherosclerosis?” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 33, no. 3, pp. 449–454, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. Q.-Y. Zhu, Q. Liu, J.-X. Chen, K. Lan, and B.-X. Ge, “MicroRNA-101 targets MAPK phosphatase-1 to regulate the activation of MAPKs in macrophages,” The Journal of Immunology, vol. 185, no. 12, pp. 7435–7442, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. Y. Fujita, K. Kojima, N. Hamada et al., “Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells,” Biochemical and Biophysical Research Communications, vol. 377, no. 1, pp. 114–119, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. Y. Li, F. Guessous, Y. Zhang et al., “MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes,” Cancer Research, vol. 69, no. 19, pp. 7569–7576, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. D. Nalls, S.-N. Tang, M. Rodova, R. K. Srivastava, and S. Shankar, “Targeting epigenetic regulation of mir-34a for treatment of pancreatic cancer by inhibition of pancreatic cancer stem cells,” PLoS ONE, vol. 6, no. 8, Article ID e24099, 2011. View at Publisher · View at Google Scholar · View at Scopus